PubMed

The effect on intraocular pressure of latanoprost once or four times daily.

Lindén C, Alm A.

Br J Ophthalmol. 2001 Oct;85(10):1163-6.PMID: 11567957 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.

Gelatt KN, MacKay EO.

Vet Ophthalmol. 2001 Dec;4(4):283-8.PMID: 11906665 [PubMed - indexed for MEDLINE]Related articles

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

Dubiner HB, Sircy MD, Landry T, Bergamini MV, Silver LH, Darell Turner F, Robertson S, Andrew RM, Weiner A, Przydryga J.

Clin Ther. 2004 Jan;26(1):84-91.PMID: 14996520 [PubMed - indexed for MEDLINE]Related articles

Latanoprost twice daily is less effective than once daily: indication of receptor subsensitivity?

Lindén C, Alm A.

Curr Eye Res. 1998 Jun;17(6):567-72.PMID: 9663846 [PubMed - indexed for MEDLINE]Related articles

Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.

Kashiwagi K, Tsukahara S.

Br J Ophthalmol. 2003 Mar;87(3):297-301.PMID: 12598441 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.

Chew PT, Aung T, Aquino MV, Rojanapongpun P; EXACT Study Group.

Ophthalmology. 2004 Mar;111(3):427-34.PMID: 15019314 [PubMed - indexed for MEDLINE]Related articles

Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.

Sponsel WE, Paris G, Trigo Y, Pena M.

Am J Ophthalmol. 2002 Oct;134(4):552-9.PMID: 12383812 [PubMed - indexed for MEDLINE]Related articles

A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.

Clin Ther. 2007 Sep;29(9):1915-23.PMID: 18035191 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure lowering effect of once daily versus once weekly latanoprost instillation in the same normal individuals.

Darhad U, Nakamura M, Fujioka M, Tatsumi Y, Nagai-Kusuhara A, Maeda H, Negi A.

Kobe J Med Sci. 2008 Feb 8;53(6):297-304.PMID: 18762724 [PubMed - indexed for MEDLINE]Related articlesFree article

Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.

Olander K, Zimmerman TJ, Downes N, Schoenfelder J; Xalacom/Latanoprost Study Group.

Clin Ther. 2004 Oct;26(10):1619-29.PMID: 15598478 [PubMed - indexed for MEDLINE]Related articles

Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.

Ishii K, Tomidokoro A, Nagahara M, Tamaki Y, Kanno M, Fukaya Y, Araie M.

Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2957-63.PMID: 11687542 [PubMed - indexed for MEDLINE]Related articlesFree article

Peak pressures: crossover study of timolol and latanoprost.

Sihota R, Saxena R, Agarwal HC, Pandey RM, Gulati V.

Eur J Ophthalmol. 2003 Jul;13(6):546-52.PMID: 12948313 [PubMed - indexed for MEDLINE]Related articles

Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

Aung T, Chew PT, Oen FT, Chan YH, Thean LH, Yip L, Lim BA, Soh J, Seah SK.

Br J Ophthalmol. 2002 Jan;86(1):75-9. Erratum in: Br J Ophthalmol 2002 Jun;86(6):707. PMID: 11801508 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study.

Larsson LI.

Acta Ophthalmol Scand. 2001 Dec;79(6):567-71.PMID: 11782220 [PubMed - indexed for MEDLINE]Related articles

Effects on intraocular pressure and aqueous flow of various dose regimens of latanoprost in human eyes.

Lindén C, Alm A.

Acta Ophthalmol Scand. 1997 Aug;75(4):412-5.PMID: 9374251 [PubMed - indexed for MEDLINE]Related articles

Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats.

Studer ME, Martin CL, Stiles J.

Am J Vet Res. 2000 Oct;61(10):1220-4.PMID: 11039551 [PubMed - indexed for MEDLINE]Related articles

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.PMID: 17415690 [PubMed - indexed for MEDLINE]Related articles

Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group.

J Glaucoma. 2005 Apr;14(2):161-7.PMID: 15741820 [PubMed - indexed for MEDLINE]Related articles

Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.

Ota T, Murata H, Sugimoto E, Aihara M, Araie M.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2006-11.PMID: 15914616 [PubMed - indexed for MEDLINE]Related articlesFree article

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles